From Zacks Investment Research: 2025-02-17 08:36:12

Stryker Corporation’s shares closed at $385.18, down 5.2% from its 52-week high. In the past six months, SYK gained 13%. The company reported strong Q4 2024 results with 10.2% organic sales growth. Stryker is expanding into high-growth markets and focusing on product innovation, with new offerings like Mako Spine and Mako Shoulder. Analysts are bullish on SYK’s prospects, but the stock trades at a premium compared to the industry. Stryker’s fundamentals are strong, but caution is advised due to its current valuation and stock trend. SYK currently holds a Zacks Rank #3 (Hold).



Read more at Zacks Investment Research: SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock? – February 17, 2025